This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Daniel R. Weinberger, MD; Douglas W. Jones, PhD; Richard Coppola, DSc; Karen Faith Berman, MD; Raymond Gibson, PhD; Richard C. Reba, MD
Clinical Brain Disorders Branch National Institute of Mental Health Neuroscience Center at St Elizabeths 2700 Martin Luther King Jr Ave SE Washington, DC 20032

Arch Neurol. 1991;48(11):1118.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—In his letter, Zeeberg questions whether the radioiodinated 3-quinuclidinyl-4-iodobenzilate (IQNB) single photon emission computed tomographic (SPECT) images in normal subjects and in patients with dementia described in our article¹ reflect primarily muscarinic receptor binding or regional cerebral blood flow (rCBF). We discussed this issue extensively in our article and spoke directly and repeatedly to the concern raised in this letter. Nevertheless, the author of this letter ignores most of our discussion and most of the in vivo data about IQNB, choosing instead to challenge a "straw man" of his own construction. He focuses on our observation regarding the cerebellum and uses this to build his case for an rCBF phenomenon. The cerebellum observation, as clearly discussed in our article, served only to demonstrate that the SPECT images at prolonged times after IQNB administration were distinctly different from, and in marked contrast to, rCBF images, and they indicated . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?